FDG-PET SUVr

Biomarker

1 paper1 finding

  • Humans1

Effects

1

Clinical conversion

no changein humans1

1 study
  1. FDG-PET SUVr has no effect on clinical conversion in humans.

    Humanspreclinical Alzheimer's diseasebrain5.8 yearsn = 127

    Metabolic brain network reorganization precedes clinical conversion in Alzheimer's disease

    bioRxiv7 Aug 2026Preprint

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01 in 12 months